M, B., E, D., A, C., A, A., C, G., P, G., . . . E, A. (2019). Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: Retrospective analyses of two phase II randomised Spanish TTD trials.
Citación estilo ChicagoM, Benavides, et al. Tumour Location and Efficacy of First-line EGFR Inhibitors in KRAS/RAS Wild-type Metastatic Colorectal Cancer: Retrospective Analyses of Two Phase II Randomised Spanish TTD Trials. 2019.
Cita MLAM, Benavides, et al. Tumour Location and Efficacy of First-line EGFR Inhibitors in KRAS/RAS Wild-type Metastatic Colorectal Cancer: Retrospective Analyses of Two Phase II Randomised Spanish TTD Trials. 2019.
Precaución: Estas citas no son 100% exactas.